LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 7.01 | 17.25 | 832 | 389 | 2.1361 | 1.3677 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 8.98 | 17.25 | 909 | 445 | 2.0424 | 1.3290 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 8.98 | 17.25 | 919 | 445 | 2.0648 | 1.3344 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 10.95 | 17.25 | 1002 | 471 | 2.1248 | 1.3421 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 10.95 | 17.25 | 958 | 471 | 2.0315 | 1.3202 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 12.91 | 17.25 | 1078 | 494 | 2.1784 | 1.3489 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 12.91 | 17.25 | 1008 | 494 | 2.0370 | 1.3165 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 14.88 | 17.25 | 1 | 534 | 0.0019 | -0.4373 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 14.88 | 17.25 | 1164 | 534 | 2.1780 | 1.3404 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 14.88 | 17.25 | 1 | 534 | 0.0019 | -0.4373 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 14.88 | 17.25 | 1085 | 534 | 2.0302 | 1.3074 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 16.85 | 17.25 | 1 | 655 | 0.0015 | -0.4188 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 16.85 | 17.25 | 1317 | 655 | 2.0089 | 1.2843 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 16.85 | 17.25 | 1 | 655 | 0.0015 | -0.4188 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 16.85 | 17.25 | 1184 | 655 | 1.8061 | 1.2385 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 18.82 | 17.25 | 1484 | 800 | 1.8538 | 1.2359 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 18.82 | 17.25 | 1361 | 800 | 1.7002 | 1.2012 | MN20160310_N02 | K13 |